Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 10, Issue 11, Pages 1799-1817
Publisher
Future Medicine Ltd
Online
2009-11-06
DOI
10.2217/pgs.09.143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis
- (2009) Betti Giusti et al. AMERICAN JOURNAL OF CARDIOLOGY
- Methods for the Measurement of Platelet Function
- (2009) Alan D. Michelson AMERICAN JOURNAL OF CARDIOLOGY
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
- (2009) D. N. Juurlink et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Can We Override Clopidogrel Resistance?
- (2009) Ana Pena et al. CIRCULATION
- Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- (2009) Kang-Yin Chen et al. CIRCULATION
- Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
- (2009) Jessica L. Mega et al. CIRCULATION
- Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
- (2009) W. Kuliczkowski et al. EUROPEAN HEART JOURNAL
- Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
- (2009) D. Sibbing et al. EUROPEAN HEART JOURNAL
- Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
- (2009) P. Michael Ho JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity
- (2009) Young-Hoon Jeong et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
- (2009) Michelle L O'Donoghue et al. LANCET
- Antiplatelet drug nonresponsiveness
- (2008) Patrick Gladding et al. AMERICAN HEART JOURNAL
- Current antiplatelet therapies: Benefits and limitations
- (2008) Dominick J. Angiolillo et al. AMERICAN HEART JOURNAL
- Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
- (2008) Jolanta M. Siller-Matula et al. AMERICAN HEART JOURNAL
- Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome
- (2008) Corinne Frere et al. AMERICAN JOURNAL OF CARDIOLOGY
- Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- (2008) Stephen D. Wiviott et al. CIRCULATION
- ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
- (2008) et al. CIRCULATION
- Coexisting Polymorphisms of P2Y12 and CYP2C19 Genes as a Risk Factor for Persistent Platelet Activation With Clopidogrel
- (2008) Lukasz A. Malek et al. CIRCULATION JOURNAL
- The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance
- (2008) KA Kim et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response
- (2008) Patrick Gladding et al. JACC-Cardiovascular Interventions
- Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel
- (2008) David S. Small et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention
- (2008) Giuseppe Patti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Elevated Plasma Fibrinogen and Diabetes Mellitus Are Associated With Lower Inhibition of Platelet Reactivity With Clopidogrel
- (2008) Lawrence Ang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo
- (2008) David Erlinge et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
- (2008) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Calcium-Channel Blockers Reduce the Antiplatelet Effect of Clopidogrel
- (2008) Jolanta M. Siller-Matula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents
- (2008) Dietmar Trenk et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjects
- (2008) K. UMEMURA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
- (2008) Tobias Geisler et al. PHARMACOGENOMICS
- Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects
- (2008) Nagy A Farid et al. PHARMACOTHERAPY
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
- (2007) Spencer B. King et al. CIRCULATION
- Heart Disease and Stroke Statistics—2008 Update
- (2007) et al. CIRCULATION
- Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19⁎2 allele on clopidogrel responsiveness
- (2007) Pierre Fontana et al. THROMBOSIS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More